These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 33530402)

  • 21. Identification of serum proteins as prognostic and predictive markers of colorectal cancer using surface enhanced laser desorption ionization-time of flight mass spectrometry.
    Helgason HH; Engwegen JY; Zapatka M; Vincent A; Cats A; Boot H; Beijnen JH; Schellens JH
    Oncol Rep; 2010 Jul; 24(1):57-64. PubMed ID: 20514444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
    Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and Verification of Two Novel Differentially Expressed Proteins from Non-neoplastic Mucosa and Colorectal Carcinoma Via iTRAQ Combined with Liquid Chromatography-Mass Spectrometry.
    Bai Y; Wang J; Gao Z; Dai E
    Pathol Oncol Res; 2020 Apr; 26(2):967-976. PubMed ID: 30927204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach.
    Xue H; Lü B; Zhang J; Wu M; Huang Q; Wu Q; Sheng H; Wu D; Hu J; Lai M
    J Proteome Res; 2010 Jan; 9(1):545-55. PubMed ID: 19924834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of Serological Early Biomarker Candidates for Lung Adenocarcinoma by using Multiple Reaction Monitoring-Mass Spectrometry.
    Wu HY; Pan YY; Kopylov AT; Zgoda V; Ma MC; Wang CH; Su WC; Lai WW; Cheng PN; Liao PC
    Proteomics Clin Appl; 2020 Jul; 14(4):e1900095. PubMed ID: 32012456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma biomarker discovery and validation for colorectal cancer by quantitative shotgun mass spectrometry and protein microarray.
    Murakoshi Y; Honda K; Sasazuki S; Ono M; Negishi A; Matsubara J; Sakuma T; Kuwabara H; Nakamori S; Sata N; Nagai H; Ioka T; Okusaka T; Kosuge T; Shimahara M; Yasunami Y; Ino Y; Tsuchida A; Aoki T; Tsugane S; Yamada T
    Cancer Sci; 2011 Mar; 102(3):630-8. PubMed ID: 21199170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolomic Profiling Identified Serum Metabolite Biomarkers and Related Metabolic Pathways of Colorectal Cancer.
    Zhang C; Zhou S; Chang H; Zhuang F; Shi Y; Chang L; Ai W; Du J; Liu W; Liu H; Zhou X; Wang Z; Hong T
    Dis Markers; 2021; 2021():6858809. PubMed ID: 34917201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of adipophilin as a potential plasma biomarker for colorectal cancer using label-free quantitative mass spectrometry and protein microarray.
    Matsubara J; Honda K; Ono M; Sekine S; Tanaka Y; Kobayashi M; Jung G; Sakuma T; Nakamori S; Sata N; Nagai H; Ioka T; Okusaka T; Kosuge T; Tsuchida A; Shimahara M; Yasunami Y; Chiba T; Yamada T
    Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2195-203. PubMed ID: 21828233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomics study of colorectal cancer and adenomatous polyps identifies TFR1, SAHH, and HV307 as potential biomarkers for screening.
    Tang M; Zeng L; Zeng Z; Liu J; Yuan J; Wu D; Lu Y; Zi J; Ye M
    J Proteomics; 2021 Jul; 243():104246. PubMed ID: 33915303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Plasma-Based Protein Marker Panel for Colorectal Cancer Detection Identified by Multiplex Targeted Mass Spectrometry.
    Jones JJ; Wilcox BE; Benz RW; Babbar N; Boragine G; Burrell T; Christie EB; Croner LJ; Cun P; Dillon R; Kairs SN; Kao A; Preston R; Schreckengaust SR; Skor H; Smith WF; You J; Hillis WD; Agus DB; Blume JE
    Clin Colorectal Cancer; 2016 Jun; 15(2):186-194.e13. PubMed ID: 27237338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An informatics-assisted label-free approach for personalized tissue membrane proteomics: case study on colorectal cancer.
    Han CL; Chen JS; Chan EC; Wu CP; Yu KH; Chen KT; Tsou CC; Tsai CF; Chien CW; Kuo YB; Lin PY; Yu JS; Hsueh C; Chen MC; Chan CC; Chang YS; Chen YJ
    Mol Cell Proteomics; 2011 Apr; 10(4):M110.003087. PubMed ID: 21209152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a new protein biomarker for colorectal cancer diagnosis.
    Zhai XH; Yu JK; Yang FQ; Zheng S
    Mol Med Rep; 2012 Aug; 6(2):444-8. PubMed ID: 22614045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Method and platform standardization in MRM-based quantitative plasma proteomics.
    Percy AJ; Chambers AG; Yang J; Jackson AM; Domanski D; Burkhart J; Sickmann A; Borchers CH
    J Proteomics; 2013 Dec; 95():66-76. PubMed ID: 23933160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of aldolase A as a potential diagnostic biomarker for colorectal cancer based on proteomic analysis using formalin-fixed paraffin-embedded tissue.
    Yamamoto T; Kudo M; Peng WX; Takata H; Takakura H; Teduka K; Fujii T; Mitamura K; Taga A; Uchida E; Naito Z
    Tumour Biol; 2016 Oct; 37(10):13595-13606. PubMed ID: 27468721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of melanotransferrin as a serological marker of colorectal cancer by secretome analysis and quantitative proteomics.
    Shin J; Kim HJ; Kim G; Song M; Woo SJ; Lee ST; Kim H; Lee C
    J Proteome Res; 2014 Nov; 13(11):4919-31. PubMed ID: 25216327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of novel plasma protein biomarkers to predict imminent cystic fibrosis pulmonary exacerbations using multiple reaction monitoring mass spectrometry.
    Quon BS; Dai DL; Hollander Z; Ng RT; Tebbutt SJ; Man SF; Wilcox PG; Sin DD
    Thorax; 2016 Mar; 71(3):216-22. PubMed ID: 25777587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LGALS4, CEACAM6, TSPAN8, and COL1A2: Blood Markers for Colorectal Cancer-Validation in a Cohort of Subjects With Positive Fecal Immunochemical Test Result.
    Rodia MT; Solmi R; Pasini F; Nardi E; Mattei G; Ugolini G; Ricciardiello L; Strippoli P; Miglio R; Lauriola M
    Clin Colorectal Cancer; 2018 Jun; 17(2):e217-e228. PubMed ID: 29352642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selected reaction monitoring for colorectal cancer diagnosis using a set of five serum peptides identified by BLOTCHIP
    Uchiyama K; Naito Y; Yagi N; Mizushima K; Higashimura Y; Hirai Y; Dohi O; Okayama T; Yoshida N; Katada K; Kamada K; Handa O; Ishikawa T; Takagi T; Konishi H; Nonaka D; Asada K; Lee LJ; Tanaka K; Kuriu Y; Nakanishi M; Otsuji E; Itoh Y
    J Gastroenterol; 2018 Nov; 53(11):1179-1185. PubMed ID: 29497816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers.
    Jimenez CR; Knol JC; Meijer GA; Fijneman RJ
    J Proteomics; 2010 Sep; 73(10):1873-95. PubMed ID: 20601272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isotope coded protein label quantification of serum proteins--comparison with the label-free LC-MS and validation using the MRM approach.
    Turtoi A; Mazzucchelli GD; De Pauw E
    Talanta; 2010 Feb; 80(4):1487-95. PubMed ID: 20082806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.